EUVIMEDEUVIMED entdecken
Crossref

MS4A4A ‐positive tumor‐associated macrophages associate with poor prognosis and T‐cell exhaustion in patients with urothelial carcinoma of the bladder

Tenghao Yang iD, Xi Sun, Jiaming Chen, Jinqing Li, Chaoqun Liu, Jingwei Yu, Weiju Meng, Yongqiang Wang, Hao Yu, Jian Huang, Bo Wang

The Journal of Pathology · 2025-10 · 267 (2) · 225-239

DOI: 10.1002/path.6465 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pathology, online erschienen am 13.08.2025. Verfasst von Tenghao Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen (Zhongshan) University, Guangzhou, PR China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Tumor-Associated Macrophages, Biomarkers, Tumor, Carcinoma, Transitional Cell. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: Guangdong Provincial Clinical Research Center for Urological Diseases, National Natural Science Foundation of China, The Science and Technology Planning Project of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor‐associated macrophages (TAMs) have multiple potent functions in cancer representing important therapeutic targets. MS4A4A is a functional TAM marker with controversial implications for prognosis. This study aimed to evaluate the association between MS4A4A + TAM infiltration and clinical outcomes in urothelial carcinoma of the bladder (UCB), as well as their impact on the immune landscape. A total of 400 UCB patients from cohorts at Sun Yat‐sen Memorial Hospital were analyzed. Immunohistochemistry was used to quantify MS4A4A + TAMs and assess their spatial distribution alongside various immune components, evaluate the benefit of Bacillus Calmette‐Guérin (BCG) immunotherapy, and analyze survival outcomes. Additionally, matched UCB tissues were examined before and after recurrence or progression. We observed that MS4A4A + TAMs were present at higher levels in the stromal region compared to the intratumoral region, and correlated with advanced tumor stage and poor prognosis in both regions. No significant difference was observed in the number of MS4A4A + TAMs before and after recurrence/progression in the same patient. Stromal MS4A4A + TAMs were negatively correlated with BCG efficacy and recurrence‐free survival. These TAMs were positively associated with CD8 + T cells, Foxp3 + regulatory T cells, immune checkpoints (PD‐1, LAG‐3, HAVcr‐2, TIGIT), and anti‐inflammatory molecules (TGF‐β1, IL‐4) in the same respective regions. Additionally, MS4A4A + TAMs expressed high levels of TGF‐β1 and HAVcr‐2 in UCB tissues. In vitro , IL‐4 induced MS4A4A expression in mouse bone marrow‐derived macrophages, while Ms4a4a knockdown reduced the anti‐inflammatory molecule Arg1 and increased pro‐inflammatory molecule Nos2 expression. These findings demonstrate that MS4A4A is a reliable prognostic marker and predictor of BCG response in UCB, highlighting its role in shaping the immune landscape and immunotherapy outcomes. © 2025 The Pathological Society of Great Britain and Ireland.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsTumor-Associated MacrophagesBiomarkers, TumorCarcinoma, Transitional CellLymphocytes, Tumor-InfiltratingHumansMaleFemaleMiddle AgedAgedBCG VaccinePrognosisTumor MicroenvironmentT-Cell Exhaustion

Stichwörter der Autor:innen

MS4A4AT‐cell exhaustionimmune checkpointmacrophageprognosisurothelial carcinoma of the bladder

Substanzen

BCG VaccineBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen (Zhongshan) University, Guangzhou, PR China.
  • Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, PR China.
  • Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances and School of Basic Medical Sciences, Guangdong Pharmaceutical University, Guangzhou, PR China.
  • Division of Hematology & Oncology, Department of Geriatrics, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, PR China.
  • Department of Pathology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, PR China.

ORCID-Profile: Tenghao Yang

Förderung

  • Guangdong Provincial Clinical Research Center for Urological Diseases
  • National Natural Science Foundation of China
  • The Science and Technology Planning Project of Guangdong Province
  • Elite Young Scholars Development Program of Sun Yat-Sen Memorial Hospital to B.W.

Zitieren

APA

Yang, T., Sun, X., Chen, J., Li, J., Liu, C., Yu, J., Meng, W., Wang, Y., Yu, H., Huang, J., & Wang, B. (2025). MS4A4A ‐positive tumor‐associated macrophages associate with poor prognosis and T‐cell exhaustion in patients with urothelial carcinoma of the bladder. The Journal of Pathology, 267(2), 225-239. https://doi.org/10.1002/path.6465

Vancouver

Yang T, Sun X, Chen J, Li J, Liu C, Yu J, et al. MS4A4A ‐positive tumor‐associated macrophages associate with poor prognosis and T‐cell exhaustion in patients with urothelial carcinoma of the bladder. The Journal of Pathology. 2025;267(2):225-239. doi:10.1002/path.6465

BibTeX
@article{Yang2025,
  author = {Yang, Tenghao and Sun, Xi and Chen, Jiaming and Li, Jinqing and Liu, Chaoqun and Yu, Jingwei and Meng, Weiju and Wang, Yongqiang and Yu, Hao and Huang, Jian and Wang, Bo},
  title = {MS4A4A ‐positive tumor‐associated macrophages associate with poor prognosis and T‐cell exhaustion in patients with urothelial carcinoma of the bladder},
  journal = {The Journal of Pathology},
  year = {2025},
  volume = {267},
  number = {2},
  pages = {225--239},
  doi = {10.1002/path.6465}
}
Kostenlos starten →